Snowdrops: The heralds of spring and a modern drug for Alzheimer's disease

Pharmaceutical Journal

Volumn 273, Issue 7330, 2004, Pages 905-906

  Heinrich, Michael ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ALKALOID; GALANTAMINE;

ALZHEIMER DISEASE; AMNESIA; ARTICLE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG COST; DRUG ISOLATION; DRUG STRUCTURE; EMOTIONAL DISORDER; ENZYME INHIBITION; ETHNOPHARMACOLOGY; GALANTHUS; HUMAN; LIFE EXPECTANCY; MEDICAL RESEARCH; MEDICINAL PLANT; NARCISSUS; NONHUMAN; SHORT TERM MEMORY; STRUCTURE ANALYSIS; SYMPTOMATOLOGY; WORLD HEALTH ORGANIZATION;

EID: 20844433007     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Heinrich M, Barnes J, Gibbons S, Williamson E.M. Fundamentals of pharmacognosy and phytotherapy. London: Churchill Livingston: 2004.
2. Plaitakis A, Duvoisin RC. Homer's moly identified as Galanthus nivalis L: physiologic antidote to stramonium poisoning. Clinical Neuropharmacology 1983;6:1-5.
3. Shellard E.J. Alkaloids from snowdrops. The Pharmaceutical Journal 2000;264:883.
4. Heinrich M, Teoh H.L. Galanthamine from snowdrop - the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. Journal of Ethnopharmacology 2004;92:147-62.
5. Erkinjunti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Venkata Damaraju CR. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomised trial. Lancet 2002;359:1283-90